Literature DB >> 12796711

Heme and iron metabolism: role in cerebral hemorrhage.

Kenneth R Wagner1, Frank R Sharp, Timothy D Ardizzone, Aigang Lu, Joseph F Clark.   

Abstract

Heme and iron metabolism are of considerable interest and importance in normal brain function as well as in neurodegeneration and neuropathologically following traumatic injury and hemorrhagic stroke. After a cerebral hemorrhage, large numbers of hemoglobin-containing red blood cells are released into the brain's parenchyma and/or subarachnoid space. After hemolysis and the subsequent release of heme from hemoglobin, several pathways are employed to transport and metabolize this heme and its iron moiety to protect the brain from potential oxidative stress. Required for these processes are various extracellular and intracellular transporters and storage proteins, the heme oxygenase isozymes and metabolic proteins with differing localizations in the various brain-cell types. In the past several years, additional new genes and proteins have been discovered that are involved in the transport and metabolism of heme and iron in brain and other tissues. These discoveries may provide new insights into neurodegenerative diseases like Alzheimer's, Parkinson's, and Friedrich's ataxia that are associated with accumulation of iron in specific brain regions or in specific organelles. The present review will examine the uptake and metabolism of heme and iron in the brain and will relate these processes to blood removal and to the potential mechanisms underlying brain injury following cerebral hemorrhage.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12796711     DOI: 10.1097/01.WCB.0000073905.87928.6D

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  156 in total

1.  Efficacy of the lipid-soluble iron chelator 2,2'-dipyridyl against hemorrhagic brain injury.

Authors:  He Wu; Tao Wu; Mingchang Li; Jian Wang
Journal:  Neurobiol Dis       Date:  2011-09-10       Impact factor: 5.996

Review 2.  Antioxidant strategies in neurocritical care.

Authors:  Khalid A Hanafy; Magdy H Selim
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

3.  Hemoglobin and iron handling in brain after subarachnoid hemorrhage and the effect of deferoxamine on early brain injury.

Authors:  Jin-Yul Lee; Richard F Keep; Yangdong He; Oren Sagher; Ya Hua; Guohua Xi
Journal:  J Cereb Blood Flow Metab       Date:  2010-08-25       Impact factor: 6.200

4.  Bipyridine, an iron chelator, does not lessen intracerebral iron-induced damage or improve outcome after intracerebral hemorrhagic stroke in rats.

Authors:  Jayalakshmi Caliaperumal; Shannon Wowk; Sarah Jones; Yonglie Ma; Frederick Colbourne
Journal:  Transl Stroke Res       Date:  2013-08-06       Impact factor: 6.829

Review 5.  Heat shock proteins in the brain: role of Hsp70, Hsp 27, and HO-1 (Hsp32) and their therapeutic potential.

Authors:  Frank R Sharp; Xinhua Zhan; Da-Zhi Liu
Journal:  Transl Stroke Res       Date:  2013-08-03       Impact factor: 6.829

6.  Micro-computed tomography for hemorrhage disruption of mouse brain vasculature.

Authors:  Bohua Xie; Peng Miao; Yuhao Sun; Yongting Wang; Guo-Yuan Yang
Journal:  Transl Stroke Res       Date:  2012-04-18       Impact factor: 6.829

7.  The Molecular Mechanisms that Promote Edema After Intracerebral Hemorrhage.

Authors:  Daniel Bodmer; Kerry A Vaughan; Brad E Zacharia; Zachary L Hickman; E Sander Connolly
Journal:  Transl Stroke Res       Date:  2012-04-12       Impact factor: 6.829

8.  Chemokines and their receptors in intracerebral hemorrhage.

Authors:  Yao Yao; Stella E Tsirka
Journal:  Transl Stroke Res       Date:  2012-04-03       Impact factor: 6.829

Review 9.  Chronic oxidative damage together with genome repair deficiency in the neurons is a double whammy for neurodegeneration: Is damage response signaling a potential therapeutic target?

Authors:  Haibo Wang; Prakash Dharmalingam; Velmarini Vasquez; Joy Mitra; Istvan Boldogh; K S Rao; Thomas A Kent; Sankar Mitra; Muralidhar L Hegde
Journal:  Mech Ageing Dev       Date:  2016-09-20       Impact factor: 5.432

10.  A preliminary study of metalloproteins in CSF by CapLC-ICPMS and NanoLC-CHIP/ITMS.

Authors:  Jenny Ellis; Estela Del Castillo; Maria Montes Bayon; Rudolf Grimm; Joseph F Clark; Gail Pyne-Geithman; Steve Wilbur; Joseph A Caruso
Journal:  J Proteome Res       Date:  2008-07-29       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.